↓ Skip to main content

ROS as a novel indicator to predict anticancer drug efficacy

Overview of attention for article published in BMC Cancer, December 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user

Citations

dimensions_citation
93 Dimensions

Readers on

mendeley
124 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
ROS as a novel indicator to predict anticancer drug efficacy
Published in
BMC Cancer, December 2019
DOI 10.1186/s12885-019-6438-y
Pubmed ID
Authors

Tarek Zaidieh, James R. Smith, Karen E. Ball, Qian An

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 124 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 124 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 20 16%
Student > Bachelor 16 13%
Researcher 10 8%
Student > Master 10 8%
Student > Doctoral Student 9 7%
Other 20 16%
Unknown 39 31%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 29 23%
Agricultural and Biological Sciences 10 8%
Chemistry 9 7%
Pharmacology, Toxicology and Pharmaceutical Science 8 6%
Medicine and Dentistry 5 4%
Other 20 16%
Unknown 43 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 March 2020.
All research outputs
#18,705,952
of 23,184,056 outputs
Outputs from BMC Cancer
#5,489
of 8,410 outputs
Outputs of similar age
#336,649
of 458,899 outputs
Outputs of similar age from BMC Cancer
#100
of 186 outputs
Altmetric has tracked 23,184,056 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,410 research outputs from this source. They receive a mean Attention Score of 4.3. This one is in the 21st percentile – i.e., 21% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 458,899 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 186 others from the same source and published within six weeks on either side of this one. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.